LOC102553417 silencing facilitates the apoptosis of hepatic stellate cells via the miR‑30e/MTDH axis-Reference-Cited by-同舟云学术

LOC102553417 silencing facilitates the apoptosis of hepatic stellate cells via the miR‑30e/MTDH axis

Published:2022-09-29 Issue:5 Volume:26 Page:
ISSN:1791-2997
Container-title:Molecular Medicine Reports
language:
Short-container-title:Mol Med Rep

Author:

Wei Wujun¹,Lin Cheng²,Hu Rentong¹,Huang Jingjing³,Chen Xiaohao¹,Zhou Lv¹,Wei Jiazhu¹,Deng Yi-Bin¹,Wang Chun-Fang¹

Affiliation:

1. Center for Clinical Laboratory Diagnosis and Research, Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, Guangxi Zhuang Autonomous Region 533000, P.R. China

2. Oncology Department, Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, Guangxi Zhuang Autonomous Region 533000, P.R. China

3. Department of Health Medicine, Baise Maternal and Child Health Hospital, Baise, Guangxi Zhuang Autonomous Region 533000, P.R. China

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology,Genetics,Molecular Biology,Molecular Medicine,Biochemistry

Reference37 articles.

1. Liver fibrosis: Mechanistic concepts and therapeutic perspectives;Roehlen;Cells,2020

2. Pathobiology of liver fibrosis: A translational success story;Lee;Gut,2015

3. Current epidemiology in hepatocellular carcinoma;Konyn;Expert Rev Gastroenterol Hepatol,2021

4. A randomized, placebo-controlled trial of emricasan in patients with NASH and F1-F3 fibrosis;Harrison;J Hepatol,2020

5. Safety, Tolerability, and preliminary efficacy of the anti-fibrotic small molecule PRI-724, a CBP/β-catenin inhibitor, in patients with hepatitis C virus-related cirrhosis: A single-center, open-label, dose escalation phase 1 trial;Kimura;EBioMedicine,2017